Advertisement
The interview gives viewers an overview of the company, and thesignificance of the company's latest press release.
To view the clip in its entirety, visit:
Advertisement
http://www.tv.wallst.net/r/3-minute-press/Ron-Andrews-CLRT-ND/278/1108
Ask Ronald Andrews a question, post a comment on his personal page, andjoin his financial social network today at:
http://my.wallst.net/Ron-Andrews-CLRT-ND
About Clarient, Inc.:
Clarient combines innovative technologies with world-class expertise toassess and characterize cancer. Clarient's mission is to provide the services,resources and critical information to improve the quality and reduce the costof patient care, and accelerate the drug development process. The Company'sprincipal customers include pathologists, oncologists, hospitals andbiopharmaceutical companies. The rise of individualized medicine as the newdirection in oncology has created the need for a centralized resourceproviding leading diagnostic technologies such as flow cytometry and moleculartesting. Clarient is that resource, having created a state-of-the-artcommercial cancer laboratory providing the most advanced oncology testing anddrug development services available both onsite and over the web. Clarient isa Safeguard Scientifics partner company. http://www.clarientinc.com.
About WallStreet Direct, Inc.
WallStreet Direct, Inc. operates WallSt.net (http://www.wallst.net), aleading source of up-to-the-minute business news, comprehensive financialtools and original multimedia content for the investment community. Inaddition to WallSt.net, WallStreet Direct owns and operates WallStRadio(http://radio.wallst.net), an online hub for business podcasts from well-knownbusiness news personalities and publishers, and WallStTV(http://tv.wallst.net), a hub for business and finance video content. We havereceived one thousand seven hundred dollars from Clarient, Inc. in 2007 formedia and advertising services, and an additional two hundred eighty dollarsfrom Clarient, Inc. for the dissemination of this press release. To read ourfull disclaimer, and for a complete list of our advertisers, and advertisingrelationships, visit http://www.wallst.net/disclaimer/disclaimer.php.Contact: WallStreet Direct, Inc. 800-4-WALLST (Logo: http://www.newscom.com/cgi-bin/prnh/20050927/LATU121LOGO )
SOURCE Clarient, Inc.; WallStreet Direct, Inc.
